Abstract: The present disclosure relates to compounds, which are useful for inhibition of BET protein function by binding to bromodomains, and their use in therapy.
Type:
Grant
Filed:
June 3, 2015
Date of Patent:
March 8, 2016
Assignee:
Zenith Epigenetics Corp.
Inventors:
David John Fairfax, Bryan Cordell Duffy, Gregory Scott Martin, John Frederick Quinn, Shuang Liu, Gregory Steven Wagner, Peter Ronald Young
Abstract: The present disclosure relates to compounds, which are useful for inhibition of BET protein function by binding to bromodomains, and their use in therapy.
Type:
Grant
Filed:
December 19, 2013
Date of Patent:
March 1, 2016
Assignee:
Zenith Epigenetics Corp.
Inventors:
Shuang Liu, Bryan Cordell Duffy, John Frederick Quinn, May Xiaowu Jiang, Ruifang Wang, Gregory Scott Martin, He Zhao, Bruce Francis Molino, Peter Ronald Young
Abstract: The present disclosure relates to compounds, which are useful for inhibition of BET protein function by binding to bromodomains, and their use in therapy.
Type:
Application
Filed:
June 3, 2015
Publication date:
December 3, 2015
Applicant:
Zenith Epigenetics Corp.
Inventors:
David John Fairfax, Bryan Cordell Duffy, Gregory Scott Martin, John Frederick Quinn, Shuang Liu, Gregory Steven Wagner, Peter Ronald Young
Abstract: The present disclosure relates to compounds, which are useful for inhibition of BET protein function by binding to bromodomains, and their use in therapy.
Type:
Grant
Filed:
November 20, 2013
Date of Patent:
July 7, 2015
Assignee:
Zenith Epigenetics Corp.
Inventors:
David John Fairfax, Bryan Cordell Duffy, Gregory Scott Martin, John Frederick Quinn, Shuang Liu, Gregory Steven Wagner, Peter Ronald Young